Advances in radiotherapy for breast cancer in 2018
10.3760/cma.j.cn113030-20190401-00115
- VernacularTitle:2018年乳腺癌放疗进展荟萃
- Author:
Jinrong XIE
1
;
Lu CAO
;
Jiayi CHEN
Author Information
1. 上海交通大学医学院附属瑞金医院放疗科 200025
- From:
Chinese Journal of Radiation Oncology
2020;29(10):913-918
- CountryChina
- Language:Chinese
-
Abstract:
In 2018, studies of radiotherapy for breast cancer mainly focus on three aspects: shorten course of radiotherapy: efficacy and safety of weekly hypofractionated whole breast irradiation (FAST and FAST FORWARD) and dose escalated intensity-modulated radiotherapy to whole breast (IMPORT HIGH); reduction in treatment volume: safety and efficacy of APBI (NSABP/RTOG 0413 and RAPID), and individualize radiotherapy decision: optimization of definition of low-risk breast cancer using clinicopathologic parameters, genomic assays and molecule subtypes. The individualized radiotherapy will be the mainstream orietation of development.
